Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.
China and US-based GluBio Therapeutics, which develops targeted protein degradation (TPD) drugs, has raised an extended Series A round of USD22m led by Qiming Venture Partners.
Taibang Biologic Group, a specialist in blood plasma-based pharmaceuticals formerly known as China Biologic Products, has raised a USD 300m round led by Abu Dhabi Investment Authority (ADIA) and GIC.
CBC Group plans to allocate USD 300m from its latest flagship fund to a biotech incubation platform. Artificial intelligence-enabled drug discovery player Ensem Therapeutics is an example of what it wants to achieve.
Gaorong Capital and Yunfeng Capital have led a USD 200m Series B round for China’s Sironax, a drug developer targeting age-related degenerative diseases.
Qiming Venture Partners and Quan Capital have led a USD 120m Series B round for OriCell Therapeutics, a China-based drug developer that is working on CAR-T cell therapies that target cancer.
Supported by a string of Chinese investors, Boston Micro Fabrication has carved a niche serving global manufacturers that want 3D printing solutions for very small components
Chinese drug developer Suzhou Ribo Life Science has raised USD 40m in the first tranche of a Series E from existing investors Panlin Capital and Trinity Innovation Fund. Several undisclosed new investors also took part.
Centurium Capital has led a USD 200m investment in NTX, a Shanghai-based textile technology start-up that aims to serve as an eco-friendly supply chain partner to fashion and apparel brands.
ABC Impact, a Singapore-based impact investor established by Temasek Trust, the philanthropic arm of Temasek Holdings, has led a USD 42m Series D for Da Mi & Xiao Mi (DMXM), a Chinese rehabilitation platform for children with autism spectrum disorder...
B Capital Group and Kunlun Capital have led a CNY 135 (USD 20m) Series A extension for China’s Prothentic Technology, a process mining specialist also known as Wangfanxin.
ClearVue Partners, a China-focused investor in consumer and technology, has reached a first close of USD 50m on a fund dedicated to digital assets related to decentralised finance (defi) services and bridging web2 and web3 operating models.
Shenzhen Capital Group has led a USD 43m Series C round for China and US-based Boston Micro Fabrication (BMF), which specialises in microscale 3D printing systems.
PAG has agreed to pay HKD 2.68bn (USD 340m) for a 51% interest in a solvents business under Hong Kong-listed petrochemical products manufacturer Yip’s Chemical.
China’s Duckbill, a fleet management platform for the trucking industry, has raised CNY 330m (USD 49m) in a Series C round led by CICC Capital.
Monad Ventures is unusual in China’s VC landscape as a dedicated software investor. Norah Tian, the firm’s founding partner, discusses valuations, deal sourcing, and gender
BAI Capital, formerly Bertelsmann Asia Investments, a captive unit of the eponymous German media company, has closed its debut China fund on approximately USD 700m.
Cix Technology, a China-based supplier of CPU chips, has raised a pre-Series-A funding round led by Nio Capital and Qiming Venture Partners. The size was not disclosed but the company claims to have raised USD 100m since inception.
Matrix Partners has led a CNY 300m (USD 44m) Series B round for SpeedBot Robotics, a China-based start-up specialising in vision-guided intelligent robotics.
Hozon Auto, a Chinese electric vehicle (EV) manufacturer, has raised CNY 3bn (USD 443m) in funding from the likes of Shenzhen Capital Group, Qianhai FoF, Hongtai Capital, Dayone Capital, Insight Capital, and Dianshi Capital.